Treatment of Infections Due to Nonsporing Anaerobes

Overview

Journal Drugs

Specialty Pharmacology

Date 1979 Aug 1

PMID 487957

Authors

M S Sprott

H R Ingham

Affiliations

Soon will be listed here.

References

Brogden R, Heel R, Speight T, Avery G . Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1979; 17(1):1-37. DOI: 10.2165/00003495-197917010-00001. View

HEINEMAN H, BRAUDE A . ANAEROBIC INFECTION OF THE BRAIN. OBSERVATIONS ON EIGHTEEN CONSECUTIVE CASES OF BRAIN ABSCESS. Am J Med. 1963; 35:682-97. DOI: 10.1016/0002-9343(63)90139-6. View

Ingham H, Eaton S, Venables C, Adams P . Bacteroides fragilis resistant to metronidazole after long-term therapy. Lancet. 1978; 1(8057):214. DOI: 10.1016/s0140-6736(78)90655-4. View

Leigh D . Clinical importance of infections due to Bacteroides fragilis and role of antibiotic therapy. Br Med J. 1974; 3(5925):225-8. PMC: 1612010. DOI: 10.1136/bmj.3.5925.225. View

Birnbaum J, Stapley E, Miller A, WALLICK H, HENDLIN D, WOODRUFF H . Cefoxitin, a semi-synthetic cephamycin: a microbiological overview. J Antimicrob Chemother. 1978; 4(B):15-32. DOI: 10.1093/jac/4.suppl_b.15. View

Sutter V, Oberhammer I, Kwok Y, Finegold S . Susceptibility of anaerobes to cefoxitin sodium and cephalothin. J Antimicrob Chemother. 1978; 4(B):41-6. DOI: 10.1093/jac/4.suppl_b.41. View

Barling R, Selkon J . The penetration of antibiotics into cerebrospinal fluid and brain tissue. J Antimicrob Chemother. 1978; 4(3):203-27. DOI: 10.1093/jac/4.3.203. View

Ingham H, KALBAG R, Tharagonnet D, High A, Sengupta R, Selkon J . Abscesses of the frontal lobe of the brain secondary to covert dental sepsis. Lancet. 1978; 2(8088):497-9. DOI: 10.1016/s0140-6736(78)92220-1. View

Keusch G, OCONNELL C . The susceptibility of bacteroides to the penicillins and cephalothin. Am J Med Sci. 1966; 251(4):428-32. DOI: 10.1097/00000441-196604000-00007. View

10.

. Lincomycin and clindamycin colitis. Br Med J. 1974; 4(5936):65-6. PMC: 1612153. View

11.

Ings R, McFADZEAN J, Ormerod W . The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms. Biochem Pharmacol. 1974; 23(9):1421-9. DOI: 10.1016/0006-2952(74)90362-1. View

12.

Willis A, FERGUSON I, Jones P, Phillips K, Tearle P, Berry R . Metronidazole in prevention and treatment of bacteroides infections after appendicectomy. Br Med J. 1976; 1(6005):318-21. PMC: 1638715. DOI: 10.1136/bmj.1.6005.318. View

13.

Willis A . The treatment of anaerobic bacterial infections. Br J Hosp Med. 1978; 20(5):579-85. View

14.

van Winzum C . Clinical safety and tolerance of cefoxitin sodium: an overview. J Antimicrob Chemother. 1978; 4(B):91-104. DOI: 10.1093/jac/4.suppl_b.91. View

15.

Ingham H, Rich G, Selkon J, Hale J, Roxby C, BETTY M . Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis. J Antimicrob Chemother. 1975; 1(2):235-42. DOI: 10.1093/jac/1.2.235. View

16.

Ingham H, Selkon J, Codd A, Hale J . The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro. J Clin Pathol. 1970; 23(3):254-8. PMC: 474534. DOI: 10.1136/jcp.23.3.254. View

17.

Bartlett J, Gorbach S, Tally F, Finegold S . Bacteriology and treatment of primary lung abscess. Am Rev Respir Dis. 1974; 109(5):510-8. DOI: 10.1164/arrd.1974.109.5.510. View

18.

Sutter V, Finegold S . Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. J Infect Dis. 1975; 131(4):417-22. DOI: 10.1093/infdis/131.4.417. View

19.

WHELAN J, Hale J . Bactericidal activity of metronidazole against Bacteroides fragilis. J Clin Pathol. 1973; 26(6):393-5. PMC: 477766. DOI: 10.1136/jcp.26.6.393. View

20.

Ingham H, Dutton J, Sisson P, Sprott M, Selkon J . An aid to the preliminary identification of non-sporing anaerobes. J Clin Pathol. 1978; 31(8):806-7. PMC: 1145411. DOI: 10.1136/jcp.31.8.806. View